Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Molecular Templates Inc MTEM

Healthcare Biotechnology
Molecular Templates, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted biologic therapeutics. The Company’s proprietary drug platform technology, known as engineered toxin bodies (ETBs), leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MTEM)

Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism

GlobeNewswire 10 days ago

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

GlobeNewswire March 29, 2024

Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement

GlobeNewswire March 28, 2024

Molecular Templates, Inc. Provides Interim Update

GlobeNewswire March 4, 2024

Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire February 8, 2024

Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update

GlobeNewswire November 13, 2023

Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors

GlobeNewswire November 2, 2023

Molecular Templates to Participate in Upcoming Investor Conferences

GlobeNewswire November 1, 2023

Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer

GlobeNewswire September 28, 2023
View More News ››

Opinion & Analysis (NDAQ:MTEM)

Biotech with solid pipeline and 'solid partnership outlook'

Streetwise Reports November 14, 2017

2017 Small-Cap biotech watchlist update: holding steady in a volatile market

The Life Sciences Report April 21, 2017

2017 Small-Cap Biotech Watchlist: takeaways for investors

The Life Sciences Report January 19, 2017

19 companies selected for the 2017 Small-Cap Biotech Watchlist

The Life Sciences Report January 5, 2017

How three companies have been resurrected from failed clinical trials:George Zavoico of JonesTrading

The Life Sciences Report April 6, 2016

Art of trading penny stocks

Ryan Fitzwater April 10, 2012
View More Opinion ››

Bullboard Posts (NDAQ:MTEM)

4 BIOTECH STOCKS THAT WARRANT YOUR ATTENTION!

$MTEM $STRO $SNDX $KRYS Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of these...
AviseAnalytics - October 5, 2021

Alert ticker Asti otc gains of 11% crossed 10ma trendline

ATTENTION ATTENTION $ASTI SALES ARE UP, the OFFICIAL SHORT SQUEEZE WILL CAUSE the SHORTS TO COVER AT HIGHER PRICES.  Currently...
kseanng - September 23, 2016

Finally

I"ve been waiting so long for upswing. Nice.
JawDrop - July 13, 2010

people are in

Does people are in this stock ??? I'm full I will buy more if it past 4$ I will buy 10 000 more shares
bonoway - January 18, 2007

people are in

Does people are in this stock ??? I'm full I will buy more if it past 4$ I will buy 10 000 more shares
bonoway - January 18, 2007

buy confimed

http://www.americanbulls.com/StockPage.asp?CompanyTicker=THLD&MarketTicker=NASD&TYP=S
bonoway - September 12, 2006
View more Bullboard ››

Tenet Fintech Group Inc.

Tenet Fintech Group Inc.

Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial ...
View More »